Dimensional Fund Advisors
ITRM

Dimensional Fund Advisors’s Iterum Therapeutics ITRM Stock Holding History

Dimensional Fund Advisors’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$101K Buy
+62,301
New +$189K ﹤0.01% 3328

Other funds holding ITRM

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Dimensional Fund Advisors's ITRM Position: Q3 2022 in Review

Dimensional Fund Advisors opened a new position in Iterum Therapeutics (ITRM) in Q3 2022: 62,301 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #3328 among its holdings.

25 funds tracked by Wall St. Rank hold ITRM as of Q3 2022.

  • Dimensional Fund Advisors held 62,301 shares of Iterum Therapeutics worth $101K as of Q3 2022.
  • Iterum Therapeutics was a new Dimensional Fund Advisors position in Q3 2022.
  • Iterum Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3328 holding.
  • 25 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.